Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-432967
Filing Date
2013-11-07
Accepted
2013-11-07 16:37:24
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d586116d10q.htm 10-Q 730037
2 EX-31.1 d586116dex311.htm EX-31.1 6252
3 EX-31.2 d586116dex312.htm EX-31.2 6262
4 EX-32 d586116dex32.htm EX-32 4968
  Complete submission text file 0001193125-13-432967.txt   3953486

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snts-20130930.xml EX-101.INS 488734
6 XBRL TAXONOMY EXTENSION SCHEMA snts-20130930.xsd EX-101.SCH 40796
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snts-20130930_cal.xml EX-101.CAL 57250
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snts-20130930_def.xml EX-101.DEF 200519
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE snts-20130930_lab.xml EX-101.LAB 283030
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snts-20130930_pre.xml EX-101.PRE 239256
Mailing Address 3611 VALLEY CENTRE DRIVE STE 400 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE STE 400 SAN DIEGO CA 92130 8583145700
SANTARUS INC (Filer) CIK: 0001172480 (see all company filings)

EIN.: 330734433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50651 | Film No.: 131201116
SIC: 2834 Pharmaceutical Preparations